Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational tools

Bibliographic Information
Authors: Sebastian-Perez V.; García-Rubia A.; Seif el-Din S.H.; Sabra A.-N.A.; El-Lakkany N.M.; William S.; Blundell T.L.; Maes L.; Martinez A.; Campillo N.E.; Botros S.S.; Gil C.
Journal: Journal of Enzyme Inhibition and Medicinal Chemistry
Publisher: Taylor and Francis Ltd
Publication Date: 15 January 2020
Volume / Issue: Volume 35 / Issue 1
Pages: 511–523
ISSN: 14756366
DOI: 10.1080/14756366.2020.1712595
Scopus: View on Scopus
PubMed: 31939312
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Sebastian-Perez V., Centro de Investigaciones Biológicas (CIB-CSIC), Madrid, Spain; García-Rubia A., Centro de Investigaciones Biológicas (CIB-CSIC), Madrid, Spain; Seif el-Din S.H., Pharmacology Department, Theodor Bilharz Research Institute, Giza, Egypt; Sabra A.-N.A., Pharmacology Department, Theodor Bilharz Research Institute, Giza, Egypt; El-Lakkany N.M., Pharmacology Department, Theodor Bilharz Research Institute, Giza, Egypt; William S., Parasitology Department, Theodor Bilharz Research Institute, Giza, Egypt; Blundell T.L., Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom; Maes L., Laboratory for Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Antwerp, Belgium; Martinez A., Centro de Investigaciones Biológicas (CIB-CSIC), Madrid, Spain; Campillo N.E., Centro de Investigaciones Biológicas (CIB-CSIC), Madrid, Spain; Botros S.S., Pharmacology Department, Theodor Bilharz Research Institute, Giza, Egypt; Gil C., Centro de Investigaciones Biológicas (CIB-CSIC), Madrid, Spain
Abstract
A previous phenotypic screening campaign led to the identification of a quinazoline derivative with promising in vitro activity against Schistosoma mansoni. Follow-up studies of the antischistosomal potential of this candidate are presented here. The in vivo studies in a S. mansoni mouse model show a significant reduction of total worms and a complete disappearance of immature eggs when administered concomitantly with praziquantel in comparison with the administration of praziquantel alone. This fact is of utmost importance because eggs are responsible for the pathology and transmission of the disease. Subsequently, the chemical optimisation of the structure in order to improve the metabolic stability of the parent compound was carried out leading to derivatives with improved drug-like properties. Additionally, the putative target of this new class of antischistosomal compounds was envisaged by using computational tools and the binding mode to the target enzyme, aldose reductase, was proposed. © 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Keywords
Drug discovery; quinazoline; Schistosoma mansoni; target deconvolution; Aldehyde Reductase; Animals; Anthelmintics; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Mice; Models, Molecular; Molecular Structure; Quinazolines; Structure-Activity Relationship; 1 [4 (trifluoromethyl)benzyl] 6,7 dimethoxy 3 (4 methoxybenzyl)quinazolin 2,4(1h,3h) dione; 1 [4 (trifluoromethyl)benzyl]3 (4 methoxybenzyl)quinazolin2,4(1h,3h) dione; 3 (4 fluorobenzyl) 1 [4 (trifluoromethyl)benzyl] 6,7 dimethoxyquinazolin 2,4(1h,3h) dione; 3 (4 fluorobenzyl) 1 [4 (trifluoromethyl)benzyl]quinazolin 2, 4(1h,3h) dione; 3 benzyl 1 [4 (trifluoromethyl)benzyl]quinazoline 2,4(1h,3h)dione; 6 bromo 1 [4 (trifluoromethyl)benzyl] 3 (4 methoxybenzyl)quinazolin 2,4(1h,3h) dione; 6 bromo 3 (4 fluorobenzyl) 1 [4 (trifluoromethyl)benzyl]quinazolin 2,4(1h,3h) dione; 6 chloro 1 [4 (trifluoromethyl)benzyl] 3 (4 methoxybenzyl)quinazolin 2,4(1h,3h) dione; 6 chloro 3 (4 fluorobenzyl) 1 [4 (trifluoromethyl)benzyl]quinazolin 2,4(1h,3h) dione; 7 bromo 1 [4 (trifluoromethyl)benzyl] 3 (4 methoxybenzyl)quinazolin 2,4(1h,3h) dione; 7 bromo 3 (4 fluorobenzyl) 1 [4 (trifluoromethyl)benzyl]quinazolin 2,4(1h,3h) dione; 8 bromo 1 [4 (trifluoromethyl)benzyl] 3 (4 methoxybenzyl) 6 methylquinazolin 2,4(1h,3h) dione; 8 bromo 3 (4 fluorobenzyl) 1 [4 (trifluoromethyl)benzyl] 6 methylquinazolin 2,4(1h,3h) dione; antischistosomal agent; praziquantel; quinazoline derivative; unclassified drug; anthelmintic agent; enzyme inhibitor; animal experiment; animal model; antiparasitic activity; Article; carbon nuclear magnetic resonance; comparative study; controlled study; crystal structure; drug screening; follow up; human; in vitro study; in vivo study; liver microsome; metabolic stability; microsome; molecular docking; mouse; nonhuman; priority journal; proton nuclear magnetic resonance; animal; chemical structure; chemistry; dose response; drug effect; enzymology; metabolism; molecular model; structure activity relation; synthesis
Citation Information
Scopus Citations: 6
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
